Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 8, Pages 3832
Publisher
MDPI AG
Online
2021-04-07
DOI
10.3390/ijms22083832
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A first-in-human study of 11C-MTP38, a novel PET ligand for phosphodiesterase 7
- (2021) Manabu Kubota et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression
- (2020) Patrik Fazio et al. MOVEMENT DISORDERS
- Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D
- (2020) Yuichi Wakabayashi et al. ACS Chemical Neuroscience
- Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist
- (2020) Giovanni Ribaudo et al. ACS Chemical Neuroscience
- PET imaging of phosphodiesterase-4 identifies affected dysplastic bone in McCune-Albright syndrome, a genetic mosaic disorder
- (2020) Lora Deuitch Weidner et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [18F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy
- (2020) Susann Schröder et al. MOLECULES
- Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent
- (2020) Zhidong Xu et al. APPLIED RADIATION AND ISOTOPES
- Rapid identification of a novel phosphodiesterase 7B tracer for receptor occupancy studies using LC─MS/MS
- (2020) Jie Chen et al. NEUROCHEMISTRY INTERNATIONAL
- Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
- (2020) Marianna Szczypka INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
- (2020) Abid Bhat et al. PHARMACOLOGICAL RESEARCH
- Pharmacological inhibition of phosphodiesterase 7 enhances consolidation processes of spatial memory
- (2020) Susan McQuown et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659
- (2019) Marie M. Svedberg et al. BRAIN RESEARCH
- The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
- (2019) Heather Wilson et al. PARKINSONISM & RELATED DISORDERS
- Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18
- (2019) Barbara Wenzel et al. BIOORGANIC CHEMISTRY
- Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study
- (2019) Jonas Persson et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders
- (2019) Mark E. Gurney et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetics-Driven Optimization of 4(3H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension
- (2019) Zhen Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation
- (2019) Limeng Jia et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 2: Focus on Schizophrenia
- (2019) Artur Świerczek et al. CURRENT DRUG TARGETS
- Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors
- (2019) Ritawidya et al. MOLECULES
- Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease
- (2019) Gennaro Pagano et al. MOVEMENT DISORDERS
- Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
- (2019) Ritawidya et al. MOLECULES
- Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease
- (2019) Fugui Dong et al. APPLIED RADIATION AND ISOTOPES
- In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains
- (2018) Hui Liu et al. ACS Chemical Neuroscience
- Phosphodiesterase 10 Inhibitors – Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery
- (2018) Agnieszka Zagorska et al. CURRENT MEDICINAL CHEMISTRY
- [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice
- (2018) Maarten Ooms et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain
- (2018) René Blöcher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
- (2018) Christopher J. Helal et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[11C]Rolipram
- (2018) Akihiro Takano et al. MOLECULAR IMAGING AND BIOLOGY
- Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
- (2018) Susann Schröder et al. MOLECULES
- Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates
- (2018) Vladimir Stepanov et al. NUCLEAR MEDICINE AND BIOLOGY
- MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease
- (2018) Daniele Bertoglio et al. PLoS One
- Imaging phosphodiesterase-10a availability in cocaine use disorder with [11 C]IMA107 and PET
- (2018) Savannah Tollefson et al. SYNAPSE
- Development of 2-(2-(3-(4-([18F]Fluoromethoxy-d2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione for Positron-Emission-Tomography Imaging of Phosphodiesterase 10A in the Brain
- (2018) Wakana Mori et al. JOURNAL OF MEDICINAL CHEMISTRY
- PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
- (2018) Flavia Niccolini et al. MOVEMENT DISORDERS
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes
- (2017) Jianrong Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Quantification of human brain PDE4 occupancy by GSK356278: A [11C](R)-rolipram PET study
- (2017) Jasper van der Aart et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease
- (2017) Jole Fiorito et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging
- (2017) Lei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease
- (2017) Michel Koole et al. MOVEMENT DISORDERS
- Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect
- (2017) Patrik Fazio et al. NEUROIMAGE
- Loss of phosphodiesterase 4 in Parkinson disease
- (2017) Flavia Niccolini et al. NEUROLOGY
- In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects
- (2017) Marielle Delnomdedieu et al. NEUROPHARMACOLOGY
- Comparison between [ 18 F]fluorination and [ 18 F]fluoroethylation reactions for the synthesis of the PDE10A PET radiotracer [ 18 F]MNI-659
- (2017) Wakana Mori et al. NUCLEAR MEDICINE AND BIOLOGY
- Aberrant spontaneous neural activity and correlation with evoked-brain potentials in first-episode, treatment-naïve patients with deficit and non-deficit schizophrenia
- (2017) Zhe Li et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study
- (2017) R Bodén et al. Translational Psychiatry
- Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy
- (2016) Christine P. Diggle et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Phosphodiesterase 10A in Schizophrenia: A PET Study Using [11C]IMA107
- (2016) Tiago Reis Marques et al. AMERICAN JOURNAL OF PSYCHIATRY
- A novel thermoregulatory role for PDE10A in mouse and human adipocytes
- (2016) Mohammed K Hankir et al. EMBO Molecular Medicine
- Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines
- (2016) Sally Wagner et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
- (2016) Kai-Chun Yang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
- (2016) Andrew F. Teich et al. JOURNAL OF ALZHEIMERS DISEASE
- Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F]AQ28A
- (2016) Sally Wagner et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Carbon-11 and Fluorine-18 Radiolabeled Pyridopyrazinone Derivatives for Positron Emission Tomography (PET) Imaging of Phosphodiesterase-5 (PDE5)
- (2016) Rufael Chekol et al. JOURNAL OF MEDICINAL CHEMISTRY
- [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP
- (2016) Maarten Ooms et al. JOURNAL OF NEUROCHEMISTRY
- Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme
- (2016) L. Chen et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430
- (2016) M. Naganawa et al. JOURNAL OF NUCLEAR MEDICINE
- Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers
- (2016) Heather Wilson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor
- (2016) M Fujita et al. MOLECULAR PSYCHIATRY
- DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1
- (2016) M Niwa et al. MOLECULAR PSYCHIATRY
- Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
- (2016) Susann Schröder et al. MOLECULES
- A human [ 11 C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor
- (2016) Akihiro Takano et al. NEUROIMAGE
- Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging
- (2016) David S. Russell et al. NEUROLOGY
- Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
- (2016) Vahri Beaumont et al. NEURON
- Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11C]T-773 in nonhuman primates
- (2016) Akihiro Takano et al. SYNAPSE
- Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease
- (2015) Flavia Niccolini et al. BRAIN
- Development of a series of novel carbon-11 labeled PDE10A inhibitors
- (2015) Vladimir Stepanov et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate
- (2015) Junfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject
- (2015) Hui Liu et al. NEUROIMAGE
- Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A
- (2015) Akina Harada et al. NUCLEAR MEDICINE AND BIOLOGY
- Synthesis and preclinical evaluation of an 18 F labeled PDE7 inhibitor for PET neuroimaging
- (2015) David Thomae et al. NUCLEAR MEDICINE AND BIOLOGY
- Evaluation of a novel PDE10APET radioligand, [11C]T-773, in nonhuman primates: Brain and whole body PET and brain autoradiography
- (2015) Akihiro Takano et al. SYNAPSE
- Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
- (2015) Alan Talevi Frontiers in Pharmacology
- Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate
- (2014) Jinda Fan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
- (2014) Chong Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease
- (2014) Surbhi Gupta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discovery of 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor
- (2014) Jun Kunitomo et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Discovery and Development of 11C-Lu AE92686 as a Radioligand for PET Imaging of Phosphodiesterase10A in the Brain
- (2014) J. Kehler et al. JOURNAL OF NUCLEAR MEDICINE
- Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
- (2014) C. Plisson et al. JOURNAL OF NUCLEAR MEDICINE
- Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer’s Disease
- (2014) Mark E. Gurney et al. Neurotherapeutics
- Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A
- (2014) Maarten Ooms et al. NUCLEAR MEDICINE AND BIOLOGY
- Poster #S45 DEVELOPMENT OF NOVEL PET LIGANDS (PF-04831704 AND PF-06327104) FOR PDE10A
- (2014) Karen M. Ward et al. SCHIZOPHRENIA RESEARCH
- Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1
- (2014) John M. Humphrey et al. MedChemComm
- The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease
- (2014) David S. Russell et al. JAMA Neurology
- PDE2 inhibition: Potential for the treatment of cognitive disorders
- (2013) Laurent Gomez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Select 3′,5′-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain
- (2013) Michy P. Kelly et al. CELLULAR SIGNALLING
- Genetic Deletion and Pharmacological Inhibition of Phosphodiesterase 10A Protects Mice From Diet-Induced Obesity and Insulin Resistance
- (2013) A. R. Nawrocki et al. DIABETES
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
- (2013) Albert Giralt et al. HIPPOCAMPUS
- Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand
- (2013) Lei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantification of 18F-JNJ-42259152, a Novel Phosphodiesterase 10A PET Tracer: Kinetic Modeling and Test-Retest Study in Human Brain
- (2013) K. Van Laere et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A
- (2013) S. Celen et al. NEUROIMAGE
- Differential striatal spine pathology in Parkinson’s disease and cocaine addiction: A key role of dopamine?
- (2013) R.M. Villalba et al. NEUROSCIENCE
- Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington’s Disease
- (2013) Ana Saavedra et al. PLoS One
- Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder
- (2012) Masahiro Fujita et al. BIOLOGICAL PSYCHIATRY
- PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
- (2012) Serap Gur et al. CURRENT PHARMACEUTICAL DESIGN
- Recent Advances in Positron Emission Tomography (PET) Radiotracers for Imaging Phosphodiesterases
- (2012) Jose Ignacio Andres et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- PDE Inhibition and cognition enhancement
- (2012) Arjan Blokland et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Phosphodiesterase 10A inhibitors: a 2009 – 2012 patent update
- (2012) Jan Kehler EXPERT OPINION ON THERAPEUTIC PATENTS
- Phosphodiesterases in neurodegenerative disorders
- (2012) Eva Bollen et al. IUBMB LIFE
- Current Landscape of Phosphodiesterase 10A (PDE10A) Inhibition
- (2012) Thomas A. Chappie et al. JOURNAL OF MEDICINAL CHEMISTRY
- The distribution of phosphodiesterase 2A in the rat brain
- (2012) D.T. Stephenson et al. NEUROSCIENCE
- Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain
- (2012) Emily M. Johansson et al. NEUROSCIENCE LETTERS
- Aberrant intrinsic brain activity and cognitive deficit in first-episode treatment-naive patients with schizophrenia
- (2012) Z. He et al. PSYCHOLOGICAL MEDICINE
- Synthesis and in vitro biological evaluation of pyrazole group-containing analogues for PDE10A
- (2012) Junfeng Li et al. MedChemComm
- Polypharmacology: drug discovery for the future
- (2012) A Srinivas Reddy et al. Expert Review of Clinical Pharmacology
- Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain
- (2011) Zhude Tu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
- (2011) Thérèse Keravis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Analysis of (R)- and (S)-[11C]rolipram Kinetics in Canine Myocardium for the Evaluation of Phosphodiesterase-4 with PET
- (2011) Mireille Lortie et al. MOLECULAR IMAGING AND BIOLOGY
- Linking neurodevelopmental and synaptic theories of mental illness through DISC1
- (2011) Nicholas J. Brandon et al. NATURE REVIEWS NEUROSCIENCE
- Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
- (2011) Jose A. Morales-Garcia et al. PLoS One
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
- (2010) Viktor Lakics et al. NEUROPHARMACOLOGY
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells
- (2009) Patricia de Gortari et al. BRAIN RESEARCH
- Immunohistochemical Localization of Phosphodiesterase 2A in Multiple Mammalian Species
- (2009) Diane T. Stephenson et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†† Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).
- (2009) Patrick R. Verhoest et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
- (2009) S. M. Grauer et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Localization of cerebral functional deficits in treatment-naive, first-episode schizophrenia using resting-state fMRI
- (2009) Xiao-Qi Huang et al. NEUROIMAGE
- PDE7 inhibitors as new drugs for neurological and inflammatory disorders
- (2008) Carmen Gil et al. EXPERT OPINION ON THERAPEUTIC PATENTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now